top of page
Browse by category
Search


Phenomix AI algorithm can predict GLP-1 side effects
Phenomix Sciences, working in partnership with Mayo Clinic researchers, has presented new data showing its proprietary machine-learning...


Journal Watch 12/3/2025
Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...


GLP-1 coverage in employer plans could double in 2024
Findings from a recent employer survey on sentiment and adoption of GLP-1 medications by Accolade and Savanta on sentiment and adoption...


European Medicines Agency to discuss anaesthesia risk for weight-loss drugs
The European Medicines Agency (EMA) will assess the risk that patients on weight loss drugs such as semaglutide and tirzepatide may...
Browse by tag






bottom of page